NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2021, Vol. 33 ›› Issue (2): 179-187.doi: 10.16333/j.1001-6880.2021.2.001

    Next Articles

Principal component analysis of active flavonoid compounds from different species of Epimedium and its protective effect on kidney-yang deficiency rats

YANG Yang1,YIN Cheng-cheng1, CHEN Hao-yuan2,LI Jia-qi1,ZHAO Da-qing1,SUI Bo-wen1,QI Bin2*   

  1. 1Jilin Ginseng Academy,Changchun University of Chinese Medicine;2Collegel of Pharmacy,Changchun University of Chinese Medicine,Changchun 130117,China

  • Online:2021-02-28 Published:2021-03-03

Abstract:

The flavonoids of Epimedium,namely icariin,epimedin A,epimedin B and epimedin C,were determined by HPLC.Combined with principal component analysis (PCA),the quality of different species of Epimedium was analyzed and evaluated. Moreover,the protective effect of Epimedium on kidney-yang deficiency in rats was also investigated.The experimental animals were randomly divided into yang deficiency model control group (model group),Jinkui Shenqi pill intervention group (positive group),Epimedium low (125 mg/kg),medium (250 mg/kg),high (500 mg/kg) dose group.Four weeks later,uric acid (UA),creatinine (CRE) and urea nitrogen (BUN) in serum of rats with kidney-yang deficiency were measured.The results of principal component analysis showed that principal component 1 icariin,epimedin C and principal component 2 epimedin B were the main factors affecting the quality evaluation of samples.The 12 batches of Epimedium medicinal materials were of good overall quality.The pharmacological results showed that compared with the blank group,the levels of UA,CRE and BUN in rat serum were significantly reduced.The above results indicated that the method measured four effective constituents of Epimedium flavonoids in the meantime,which provided a reference for establishing quality evaluation system of Epimedium;Epimedium has obvious protective effect on hydrocortisone-induced kidney-yang deficiency and has a dose-effect relationship.

Key words: four active ingredients, content determination, principal component analysis, kidney yang deficiency

CLC Number: